ESR1 and breast carcinoma: Given the scarcity of clinically accessible TNBC tissue samples, this study concentrated on a heterogeneous collection of breast cancer cell lines without comprehensive characterization of their hormonal receptor (ER/PR) and HER2 expression profiles.